Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
BMC Cancer|September 24, 2013
Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancerJun-Eul Hwang, Ji-Yun Hong, Karham Kim, et al.Nature Communications|October 21, 2017
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancersChan-Young Ock, Jun-Eul Hwang, Bhumsuk Keam, et al.Cancer Science|June 14, 2020
Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancerChang-Soo Hong, Eun-Gene Sun, Ji-Na Choi, et al.Oncotarget|October 15, 2017
The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysisJun Eul Hwang, Myung Seo Ki, Karham Kim, et al.Korean Journal of Urology|July 22, 2014
Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic scoreYang Hyun Cho, Young Ho Seo, Seung Jun Chung, et al.Korean Journal of Urology|May 24, 2013
Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stentsSeong Hyeon Yu, Je Guk Ryu, Se Heon Jeong, et al.Journal of Korean Medical Science|December 15, 2018
Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and PazopanibMyung Soo Kim, Ho Seok Chung, Eu Chang Hwang, et al.Clinical & Experimental Metastasis|August 27, 2013
Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancerJun-Eul Hwang, Seung-Hun Kim, Joon Jin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2020
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse eventsChanghoon Yoo, Seonggyu Byeon, Yeonghak Bang, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2020
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective studyHyung-Don Kim, Yeonghak Bang, Myung Ah Lee, et al.Pageof 11